| __timestamp | Supernus Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 116287000 | 1162636000 |
| Thursday, January 1, 2015 | 136004000 | 1396725000 |
| Friday, January 1, 2016 | 203017000 | 1526100000 |
| Sunday, January 1, 2017 | 287023000 | 1619600000 |
| Monday, January 1, 2018 | 393541000 | 1429100000 |
| Tuesday, January 1, 2019 | 376095000 | 1331200000 |
| Wednesday, January 1, 2020 | 467938000 | 1375200000 |
| Friday, January 1, 2021 | 504714000 | 1563000000 |
| Saturday, January 1, 2022 | 580017000 | 1789600000 |
| Sunday, January 1, 2023 | 523742000 | 2070000000 |
Unleashing the power of data
In the competitive landscape of biopharmaceuticals, United Therapeutics Corporation and Supernus Pharmaceuticals, Inc. have showcased distinct trajectories in gross profit performance from 2014 to 2023. United Therapeutics, a leader in the field, consistently outperformed its peer, with gross profits peaking at approximately $2.07 billion in 2023, marking a 78% increase from 2014. Meanwhile, Supernus Pharmaceuticals demonstrated steady growth, achieving a gross profit of around $524 million in 2023, a remarkable 350% rise since 2014.
This decade-long analysis highlights United Therapeutics' robust market position, maintaining an average gross profit nearly four times that of Supernus. However, Supernus' impressive growth rate underscores its potential to capture a larger market share. As the biopharmaceutical industry evolves, these companies' financial performances offer valuable insights into their strategic directions and market dynamics.
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Alkermes plc and Supernus Pharmaceuticals, Inc.
MorphoSys AG vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown